Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2022-03-30 Annual Report
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting in Medistim ASA
Annual Report Classification · 100% confidence The document is titled 'CORPORATE ANNUAL REPORT 2021' and contains a comprehensive table of contents including key figures, letter from the CEO, board of director's report, consolidated financial statements, and auditor's report. It covers the full fiscal year 2021 and provides detailed financial and operational performance data, which aligns perfectly with the definition of an Annual Report (10-K). FY 2021
2022-03-30 English
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 98% confidence The document explicitly announces the 'Notice of Annual General Meeting in Medistim ASA' and provides the date, time, and location for the meeting. It also mentions that the agenda, voting form, and the annual report for 2021 are attached. Since the primary purpose is to notify shareholders about the AGM and solicit participation/voting, the most appropriate classification is AGM Information (AGM-R). Although it mentions the annual report is attached, the document itself is the notice/invitation for the meeting, not the full report or a general announcement of report publication.
2022-03-30 English
Annual report for 2021 for Medistim ASA
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-03-29 English
Annual report for 2021 for Medistim ASA
Annual Report Classification · 100% confidence The document is titled 'CORPORATE ANNUAL REPORT 2021' and contains a comprehensive table of contents including key figures, letter from the CEO, board of director's report, consolidated financial statements, and auditor's report. It covers the full fiscal year 2021 and provides detailed financial and operational performance data, which aligns perfectly with the definition of an Annual Report (10-K). FY 2021
2022-03-29 English
Annual report for 2021 for Medistim ASA
Report Publication Announcement Classification · 100% confidence The document explicitly states it is the 'Annual report for 2021 for Medistim ASA' and announces that this report 'is approved and available'. However, the document length is very short (1273 characters) and it functions primarily as an announcement stating the report's availability, rather than containing the full content of the Annual Report itself (which would typically be a 10-K or a very long document). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report is published points towards a Report Publication Announcement (RPA). Although the content is about the Annual Report, the document's format is that of a publication notice.
2022-03-29 English
Board approval of the 2021 Financial statements for Medistim ASA
Audit Report / Information Classification · 95% confidence The document explicitly states that the Board of Medistim ASA has approved the Financial Statements for 2021 and mentions that the Annual General Meeting will be held on April 27th, 2022. The text is very short (1551 characters) and serves as an announcement regarding the approval of financial statements, rather than being the full financial statements themselves (which would typically be classified as 10-K or IR). Since it announces the approval of the annual financial statements and mentions the upcoming AGM, it is most closely related to the release of annual information. However, it is not the full 10-K, nor is it a generic earnings release (ER) which usually focuses on quarterly results. Given the context of announcing the approval of the *Financial Statements for 2021* and the short nature, it functions as a preliminary announcement or a regulatory disclosure about the finalization of annual results. Since there is no specific code for 'Financial Statement Approval Announcement', and it is not a full report, the closest fit among the options that deals with the finalization of annual results is often grouped with Earnings Releases (ER) or, if it were purely about the meeting, AGM-R. Since it is an announcement about the *Financial Statements* being approved, and it is short, it could be an ER or RPA. Given the mention of the AGM date, it is highly related to the annual cycle. Because it is a brief announcement confirming the finalization of the annual financial statements, it functions as a precursor to the full filing. If it were a full report, it would be 10-K. As a short announcement confirming the finalization of the annual report, it fits best as an Earnings Release (ER) which covers period results, or potentially RPA if it were announcing the *publication* of the full document. Since it announces the *approval* of the statements, and the statements themselves are not present, I will classify it as an Earnings Release (ER) as it pertains to the finalization of the annual results, or RPA as a report publication announcement. Given the content focuses on the *Financial Statements* being approved, and it is a short disclosure, RPA (Report Publication Announcement) is a strong candidate as it announces the status of the report. However, ER is often used for the initial release of period results. Since this is the *final* approval of the *annual* statements, and it is very brief, I will lean towards RPA as it is an announcement about a report's status, or RNS as a general regulatory disclosure. Given the specific mention of 'Financial Statements for 2021' being approved, and the short length, RPA seems most appropriate as it signals the finalization before the full release, or ER if we treat the approval as the result announcement. I will select ER as it relates directly to the period's financial results being finalized, even if brief. Reconsidering the definitions: ER is 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This is the *annual* result finalization. RPA is 'Announcement regarding the timing, release, or publication of company reports'. This fits better as it announces the approval of the statements, which precedes their formal publication. I will choose RPA. FY 2021
2022-03-23 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.